Quality Assurance Inspections. original signed

Similar documents
INTERIM SITE MONITORING PROCEDURE

No Page 1 of 5. Issue Date 4/21/2014

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH

This policy applies to all clinical research conducted at Beaumont Health System.

Reliance Agreement for Institutions Utilizing Stony Brook University s Institutional Review Board(s)

The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

What is necessary to provide good clinical data for a clinical trial?

Quality Management in Clinical Trials

DAIDS Bethesda, MD USA. POLICY Requirements for Clinical Quality Management Plans

Investigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)

PROCEDURE(S) OF THE NATIONAL GLP OFFICE

Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA

POSITION DETAILS ORGANOGRAM

DHHS/NIH/OD/OIR/OHSRP 1/2/2015

Guidance for CTUs on Assessing the Suitability of Laboratories Processing Research Samples

ISO 9001:2008 STANDARD OPERATING PROCEDURES MANUAL

Document Title: Trust Approval and Research Governance

CHAPTER 5 - SAFETY ASSESSMENTS, LOG OF DEFICIENCIES AND CORRECTIVE ACTION PLANS

Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure

Regulator s Role in GCP

Clinical Trials Ontario

New Investigator Collaborations and Interactions: Regulatory

Data Manager s Role in Data Quality

[Project Name] Project Human-Resource Management Plan. [Sub-Project, phase, etc.] [Company] [Company Address]

Orientation Manual for Clinical Research Coordinators

APPENDIX 6: MASTER OF ARTS THESIS REQUIREMENTS (POLI 697 and 698)

CNE Disclosures. To change this title, go to Notes Master

Document Title: Project Management of Papworth Sponsored Studies

INTEGRATED SILICON SOLUTION, INC. CORPORATE GOVERNANCE PRINCIPLES. Effective January 9, 2015

Quality Monitoring Checklist

AUDIT AND RISK MANAGEMENT COMMITTEE CHARTER

Marie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager

Procedure for Conducting Audits and Management Reviews

Ensuring Data Quality in an EDC Study: When Traditional QC No Longer Applies

Evaluation Instrument for Accreditation January 1, 2015

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

GMP Training Course Inspections from an industry perspective October 2009 Fiona Routley MHRA Inspector (UK)

Evaluation Instrument for Accreditation January 1, 2016

I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control.

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]

2014 Metrics on Human Research Protection Program Performance

Guidance on IRB Continuing Review of Research

PHASE 9: OPERATIONS AND MAINTENANCE PHASE

Information Management Strategic Plan - Methodology

Volume 2 Compliance Process

Essential Standard Operating Procedures Sample Templates Table of Contents

Claim of Exemption Form Page 1 of 6

Health Canada s GCP Compliance Program Part 2. GCP Information Sessions November 2010

QEP PROGRAM PARTICIPANT BRIEFING

Objectives. Monitoring & Auditing of Clinical Trials. Overview. Pre-study Qualification Visit. Industry-sponsored Trials

12.0 Investigator Responsibilities

IMMUNOTEC INC. AUDIT AND DISCLOSURE POLICY MANAGEMENT COMMITTEE CHARTER AND WHISTLEBLOWER POLICY

STANDARD OPERATING PROCEDURE FOR RESEARCH. 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol

PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA. GCP Inspectors Working Group

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

FINAL DOCUMENT. Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers Part 1: General Requirements

STANDARD OPERATING PROCEDURE NO. CM

PHASE 8: IMPLEMENTATION PHASE

Equity and High Income Funds Governance and Nominating Committee Charter

Internal Audit Checklist

How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program

IOWA STATE UNIVERSITY Institutional Review Board. Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others

CLINICAL RESEARCH PROTOCOL CHECKLIST

Site visit inspection report on compliance with HTA minimum standards. London School of Hygiene & Tropical Medicine. HTA licensing number 12066

North American Electric Reliability Corporation. Compliance Monitoring and Enforcement Program. December 19, 2008

ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014

Research Coordinator - PI s who have research coordinators or secretarial support can designate individuals to manage their IRB protocols in Mentor.

Data Management Unit Research Institute for Health Sciences, Chiang Mai University

Health Sciences Compliance Plan

EMS Example Example EMS Audit Procedure

Essential Documents for Clinical Trial Research. Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office

Objectives. The Paper Tells the Story

Yale Cancer Center Data and Safety Monitoring Committee Charter

INSTITUTIONAL COMPLIANCE PLAN

Specialties Manufacturing. Talladega Castings & Machine Co., Inc. ISO 9001:2008. Quality Manual

Friday, May 2. Clinical Trials: Is Your Staff Competent? Session 10:15 11:45 am Ballroom C

DAIDS Bethesda, MD USA POLICY. Requirements for Clinical Quality Management Plans

STANDARD OPERATING POLICY AND PROCEDURE

Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research

<name of project> Software Project Management Plan

Study Protocol Template

IEEE Power and Energy Society (PES) Policies and Procedures for: Working Groups. Approved 2014 April 23 IEEE Transmission & Distribution Committee

Monitoring & Auditing of Clinical Trials. Sponsored by Center for Cancer Research National Cancer Institute

Dryden Centerwide Procedure (DCP) Code X. DMS Audit Preparation and Execution

STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders

Standard Operating Procedures

HIPAA COMPLIANCE PLAN. For. CHARLES RETINA INSTITUTE (Practice Name)

LOUISIANA DEPARTMENT OF EDUCATION SPECIAL SCHOOL PROGRAMS

Action Plan developed by Pakistan Institute of Public Finance Accountants (PIPFA) BACKGROUND NOTE ON ACTION PLANS

The Ontario Cancer Research Ethics Board Overview

COHERENT, INC. Board of Directors. Governance Guidelines

ISO :2005 Requirements Summary

Module 17: EMS Audits

Internal Audit Charters

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)

Good Documentation Practices

U. S. Department of Energy Consolidated Audit Program Checklist 5 Laboratory Information Management Systems Electronic Data Management

City of Raleigh Public Utilities Department. Wastewater EMS Manual

Transcription:

Title Quality Assurance Inspections SOP Code 901.002 Effective Date 01-July-2016 Site Approvals Name and Title (typed or printed) Karine Morin Executive Director, Platforms Signature original signed Date dd/mmm/yyyy effective 01-July-2016 1.0 PURPOSE This standard operating procedure (SOP) describes the processes for monitoring, evaluating and improving the effectiveness of the human research protection enterprise. 2.0 SCOPE This SOP pertains to Research Ethics Boards (REB) that review human participant research in compliance with applicable regulations and guidelines. 3.0 RESPONSIBILITIES All REB members, REB Office Personnel and the QA officer, if separate from the REB Office Personnel, are responsible for ensuring that the requirements of this SOP are met. 4.0 DEFINITIONS See Glossary of Terms. 5.0 PROCEDURE Quality Management programs, Quality Assurance (QA), and Quality Control (QC) activities, such as inspections of the REB and of Researchers, allow for a continuous evaluation and subsequent assurance of the human research protection enterprise. SOP 901 Quality Assurance Inspections Page 1 of 5

Findings are measured against established policies and procedures and all of the applicable ethical, legal, and regulatory requirements. When areas for improvement are identified, corrective action is taken including training, education, and the revision of SOPs. 5.1 REB Quality Assurance Inspections (Internal) 5.1.1 The QA Officer will develop a schedule for routine QA inspections or initiate ad hoc inspections in response to complaints or other concerns; 5.1.2 QA inspections may include the REB and the REB office; 5.1.3 When the QA Officer conducts a QA inspection of the REB and the REB office the inspection may including the following: An assessment of the SOPs and compliance with applicable regulations and guidance, A review of research files, REB membership rosters, REB attendance records, and REB agendas and minutes, A review of workload, performance metrics and annual reports, A review of stakeholder satisfaction surveys, An assessment of quality control procedures for compliance with the SOPs, A review of checklists, forms, and templates, Interviews with REB members, REB Office Personnel, Researchers, sponsors, and regulators, A review of training/education records, A review of all continuous improvement activities, An assessment of whether any new requirements (ethical, legal, or regulatory) were incorporated into the policies and procedures, A review of the status of any corrective action items from previous reviews, A review of any deviations from ethical, legal, or regulatory requirements, or deviations from the organization s policies, and whether the deviations require remediation, An assessment of compliance with all applicable requirements; 5.1.4 The QA Officer compares the findings against established policies, SOPs and applicable ethical, legal, and regulatory requirements; 5.1.5 The QA Officer prepares a written summary of the inspection, including areas requiring improvement; SOP 901 Quality Assurance Inspections Page 2 of 5

5.1.6 The QA Officer reports the findings to the REB Chair or designee, and to the REB and/or to the appropriate Organizational Official as required; 5.1.7 The QA Officer works with the REB Chair or designee to implement improvements (e.g. new or revised SOPs or forms, training, education, additional resources or modifications to existing resources). 5.2 Researcher Quality Assurance Inspections 5.2.1 The QA Officer will develop a schedule for routine QA inspections and implement inspections in response to Researcher requests; 5.2.2 The QA Officer will work with the REB and the organization at which the research is being conducted to determine if and when a for-cause inspection of a Researcher is warranted; 5.2.3 The REB may direct the QA Officer to conduct for-cause inspections; 5.2.4 The QA Officer or designee may request copies of the sponsor s monitoring reports for a designated research project or that a questionnaire from the REB is completed; 5.2.5 The criteria for selecting Researchers or research projects for inspection may include: The results of a previous external audit or inspection, The results of a sponsor audit, Researcher-initiated studies (i.e., where the Researcher is also the sponsor), Studies that involve a potentially high risk to participants, Studies that involve vulnerable populations, Studies in which Researchers are enrolling large numbers of participants, Suspected noncompliance, Unanticipated problems involving risks to participants or others, Suspected or reported protocol deviations, Participant complaints, Research Staff complaints, Any other situation that the REB deems appropriate; 5.2.6 The QA Officer or designee will notify the Researcher of the inspection and a mutually acceptable time will be scheduled. It may be necessary to schedule an inspection without first obtaining the formal consent of a Researcher (e.g., participant safety or suspected non-compliance); SOP 901 Quality Assurance Inspections Page 3 of 5

5.2.7 The QA Officer or designee will conduct the inspection using designated/ appropriate evaluation tools; 5.2.8 When the QA Officer conducts an inspection of the Researcher, the inspection may include some or all of the following (as applicable): An assessment of the SOPs and compliance with applicable regulations and guidance, A review of all regulatory binders including the REB approval documentation, REB approved consent documents, signed consent documents, correspondence between the Researcher and sponsor, etc., Interviews with the research staff and/or the Researcher, A review of test article accountability, A review of specimens and associated collection processes, A review of computer hardware and/or software associated with the research, A review of the consent form(s) and associated processes including eligibility requirements, A review of the completed case report forms (CRFs) or other data collection mechanisms, A review of appropriate source material (participant medical records),and A review of other documentation, as relevant and available; 5.2.9 The REB or the QA Officer may choose to have a qualified impartial observer to monitor the consent process or to interview research participants; 5.2.10 At the conclusion of the evaluation, the QA Officer or designee will discuss the findings with the Researcher; 5.2.11 The QA Officer or designee will draft a report or provide a summary of the inspection including: positive findings, areas for improvement and recommendations for corrective action, and submit the report to the REB Chair or designee for review; 5.2.12 The Researcher will be given an opportunity to respond to the report with responses and/or corrective action plans within a time specified by the REB; 5.2.13 The QA Officer or designee will send a copy of the final report to the Researcher and the REB. When applicable, the REB Chair or designee will provide the findings to the local Organizational Official. SOP 901 Quality Assurance Inspections Page 4 of 5

5.3 Corrective Action 5.3.1 The QA Officer may recommend corrective action based on the findings; 5.3.2 Corrective action may include a recommendation for the provision of additional resources, training, or education, the development of, or revisions to the SOPs, and changes to forms, checklists or templates; 5.3.3 The QA Officer will evaluate the effectiveness of the implemented improvements and adjust processes accordingly; 5.3.4 The QA Officer will follow-up with the Researcher in a timely manner to determine if the corrective actions have been implemented by the Researcher following a Researcher audit or inspection. 5.4 Documentation 5.4.1 The QA Officer or designee files all reports and correspondence concerning QA inspections in the appropriate QA Files. 6.0 REFERENCES See References. 7.0 REVISION HISTORY SOP Code Effective Date Summary of Changes SOP901.001 01 July 2016 Original version SOP901.002 01 July 2016 Version 2 - no changes SOP 901 Quality Assurance Inspections Page 5 of 5